FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology. Surgical treatment of epiretinal fibrosis is performed, in which three-port subtotal vitrectomy is performed, contrasting of the epiretinal membrane is performed using the retinal dye MembraneBlue-Dual, followed by its removal, contrasting of internal boundary membrane (IBM) and its removal, vitreal cavity is filled with BSS solution. After vitrectomy, removal of epiretinal membrane and internal boundary membrane 0.02 ml of Triamcinolone acetonide solution is introduced into vitreal cavity.
EFFECT: method enables reducing the risk of recurrence and subsequent complications, achieving not only the elimination of the traction component, but also the anti-inflammatory effect; to achieve minimum injuries, reduce the number of postoperative complications.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR REMOVAL OF FIBROUS-ALTERED POSTERIOR HYALOID FACE (PHF) IN PROLIFERATIVE RETINOPATHY | 2021 |
|
RU2759234C1 |
METHOD FOR SURGICAL MANAGEMENT OF RHEGMATOGENOUS RETINAL DETACHMENT WITH REMOVAL OF INTERNAL LIMITING MEMBRANE | 2018 |
|
RU2688963C1 |
METHOD OF INTRAOPERATIVE VISUALIZATION OF RETINA DURING ENDOVITREAL SURGERY | 2023 |
|
RU2808112C1 |
METHOD FOR SURGICAL TREATMENT OF WET MACULAR DEGENERATION COMPLICATED BY SECONDARY EPIRETINAL MEMBRANE | 2021 |
|
RU2758026C1 |
METHOD OF SURGICAL TREATMENT OF PATIENTS WITH PROLIFERATIVE VITRECTONOMY WITH SYNECHIAE REMOVAL AGAINST THE BACKGROUND OF DIABETES MELLITUS | 2017 |
|
RU2675463C1 |
METHOD OF TREATING MACULAR RUPTURE COMPLICATED BY DRUSENOID DETACHMENT OF RETINAL PIGMENT EPITHELIUM | 2022 |
|
RU2820489C1 |
METHOD FOR SURGICAL MANAGEMENT OF MACULAR RUPTURE USING AUTOLOGOUS CONDITIONED PLASMA | 2023 |
|
RU2816630C1 |
METHOD OF EXAMINING RETINAL SURFACE IN ENDOVITREAL SURGERY | 2020 |
|
RU2742758C1 |
METHOD OF STEP-BY-STEP CHROMOVITRECTOMY AT DEEP PROLIFERATIVE DIABETIC RETINOPATHY BY USING VITREOCONTRAST SUSPENSION | 2017 |
|
RU2662903C1 |
METHOD FOR SURGICAL TREATMENT OF IDIOPATHIC EPIRETINAL FIBROSIS WITH PARTIAL PRESERVATION OF INTERNAL LIMITING MEMBRANE | 2023 |
|
RU2805469C1 |
Authors
Dates
2025-02-24—Published
2024-07-11—Filed